BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3662 related articles for article (PubMed ID: 27414503)

  • 21. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
    Dillon JA; Li H; Sealy J; Ruben M; Prabhakar P;
    Sex Transm Dis; 2001 Sep; 28(9):508-14. PubMed ID: 11518867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
    Nokchan N; Wongsurawat T; Jenjaroenpun P; Nitayanon P; Tribuddharat C
    PLoS One; 2022; 17(7):e0271657. PubMed ID: 35905043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
    Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS;
    J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
    Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
    Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.
    Dillon JA; Rubabaza JP; Benzaken AS; Sardinha JC; Li H; Bandeira MG; dos Santos Fernando Filho E
    Sex Transm Dis; 2001 Sep; 28(9):521-6. PubMed ID: 11518869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012.
    Yu RX; Yin Y; Dai XQ; Chen SC; Han Y; Zheng BJ; Zhang GY; Chen XS
    Sex Transm Dis; 2017 Apr; 44(4):197-201. PubMed ID: 28282644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
    Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E
    BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
    Katz AR; Komeya AY; Kirkcaldy RD; Whelen AC; Soge OO; Papp JR; Kersh EN; Wasserman GM; O'Connor NP; O'Brien PS; Sato DT; Maningas EV; Kunimoto GY; Tomas JE
    Clin Infect Dis; 2017 Sep; 65(6):918-923. PubMed ID: 28549097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
    Bala M; Singh V; Bhargava A; Ramesh V
    Sex Transm Dis; 2015 Apr; 42(4):218-22. PubMed ID: 25763675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.
    Martin I; Jayaraman G; Wong T; Liu G; Gilmour M;
    Sex Transm Dis; 2011 Oct; 38(10):892-8. PubMed ID: 21934558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographic and Epidemiological Characteristics Associated With Reduced Antimicrobial Susceptibility to Neisseria gonorrhoeae in the United States, Strengthening the US Response to Resistant Gonorrhea, 2018 to 2019.
    Gieseker KE; Learner ER; Mauk K; Barbee LA; McNeil CJ; Hasty GL; Black JM; Johnson K; Nguyen TQ; Shrestha D; Pham CD; St Cyr S; Schlanger K; Kirkcaldy RD;
    Sex Transm Dis; 2021 Dec; 48(12S Suppl 2):S118-S123. PubMed ID: 34433798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.
    Knapp JS; Mesola VP; Neal SW; Wi TE; Tuazon C; Manalastas R; Perine PL; Whittington WL
    Sex Transm Dis; 1997 Jan; 24(1):2-7. PubMed ID: 9018776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.
    Cole MJ; Spiteri G; Jacobsson S; Pitt R; Grigorjev V; Unemo M;
    BMC Infect Dis; 2015 Aug; 15():321. PubMed ID: 26259560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines.
    Barbee LA; St Cyr SB
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S95-S111. PubMed ID: 35416971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 184.